Summary of Study ST002550

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001642. The data can be accessed directly via it's Project DOI: 10.21228/M8FX54 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002550
Study TitleTargeted metabolomics for ARDS
Study SummaryAcute respiratory distress syndrome (ARDS) is a heterogeneous disease in its etiology and clinical aspects, and it has been an important interest in how to diagnose it and classify its subtypes, and apply them to treatment. Metabolomics is becoming important for identifying ARDS biology and distinguishing subtypes. The aim of this study is to identify metabolites distinguishing sepsis-induced ARDS patients from healthy controls using a targeted metabolomics approach, and to find out whether direct and indirect ARDS are metabolically distinct groups and confirm their metabolites and associated pathways. Targeted metabolomics was performed to explore metabolome changes between pARDS (pediatric ARDS) and eARDS.
Institute
Asan Medical Center
Last NameYoo
First NameHyun Ju
Address88, Olympic-ro 43-gil, Songpa-gu
Emailyoohyunju@amc.seoul.kr
Phone0230104029
Submit Date2023-03-30
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2023-07-06
Release Version1
Hyun Ju Yoo Hyun Ju Yoo
https://dx.doi.org/10.21228/M8FX54
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN004198 AN004199
Analysis type MS MS
Chromatography type Reversed phase Reversed phase
Chromatography system Agilent 1290 Agilent 1290
Column Agilent ZORBAX Eclipse Plus C18 (50 x 2.1mm,1.8um) Agilent Pursuit 5 C18 (150 x 2.1mm,5um)
MS Type ESI ESI
MS instrument type QTRAP QTRAP
MS instrument name ABI Sciex 5500 QTrap ABI Sciex 5500 QTrap
Ion Mode POSITIVE POSITIVE
Units nM nM

Chromatography:

Chromatography ID:CH003111
Chromatography Summary:LC-MS/MS (MRM) for phospholipid
Instrument Name:Agilent 1290
Column Name:Agilent ZORBAX Eclipse Plus C18 (50 x 2.1mm,1.8um)
Column Temperature:30
Flow Gradient:isocratic condition of 60% B
Flow Rate:400 µL/min
Solvent A:10 mM ammonium acetate in MeOH/isopropanol/H2O(900/50/50)
Solvent B:10 mM ammonium acetate in MeOH/isopropanol/H2O(940/50/10)
Chromatography Type:Reversed phase
  
Chromatography ID:CH003112
Chromatography Summary:LC-MS/MS (MRM) for sphingolipid
Instrument Name:Agilent 1290
Column Name:Agilent Pursuit 5 C18 (150 x 2.1mm,5um)
Column Temperature:30
Flow Gradient:50% A for 0 min, 50% A for 5 min, 50 to 30% A for 3 min, 30% A for 7 min, 30 to 10% A for 7 min, 10% A for 3 min, 10 to 50% A for 0.1 min, and 50% A for 4.9 min
Flow Rate:200 µL/min
Solvent A:5 mM ammonium formate/MeOH/tetrahydrofuran(500/200/300)
Solvent B:5 mM ammonium formate/MeOH/tetrahydrofuran(100/200/700)
Chromatography Type:Reversed phase
  logo